Panacea Biotec Profit & Loss Annual

Trade
BSE: 531349 | NSE: PANACEABIO | ISIN: INE922B01023 | Sector: Biotechnology & Drugs
421.45 +12.00 (2.93%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 559.17459.95661.23624.81
Total Revenue 559.17459.95661.23624.81
Costof Revenue Total 230.12310.71337.83259.47
Gross Profit 329.05149.24323.40365.33
Selling/ General/ Admin Expenses Total 149.57212.51326.71275.97
Depreciation/ Amortization 36.7139.1243.6645.59
Unusual Expense( Income) -36.03-99.10-1,675.424.00
Other Operating Expenses Total 199.542.466.444.32
Total Operating Expense 579.91465.70-960.78589.36
Operating Income -20.74-5.751,622.0135.45
Interest Inc( Exp) Net- Non- Op Total -35.80117.83-1,760.48-1,820.33
Other Net 25.801.482.842.38
Net Income Before Taxes 1.4812.811,448.81-144.25
Provisionfor Income Taxes 2.9846.55370.911.96
Net Income After Taxes -1.50-33.751,077.90-146.20
Minority Interest 0.330.51-0.02-0.04
Net Income Before Extra Items -1.17-33.241,077.89-146.24
Net Income -1.17-33.241,077.89-147.70
Income Availableto Com Excl Extra Ord -1.17-33.241,077.89-146.24
Income Availableto Com Incl Extra Ord -1.17-33.241,077.89-147.70
Diluted Net Income -1.17-33.241,077.89-147.70
Diluted Weighted Average Shares 6.166.136.136.13
Diluted EPS Excluding Extra Ord Items -0.19-5.43175.98-23.88
Diluted Normalized EPS -3.99-16.50-1.82-23.45
Gain( Loss)on Saleof Assets -52.930.07-0.38
Total Extraordinary Items --0.00-1.46
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts